We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

185 hedge funds and large institutions have $468M invested in Immunogen Inc in 2020 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 72 increasing their positions, 46 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more call options, than puts

Call options by funds: $1.01M | Put options by funds: $566K

57% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 46

6% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 34

3% less funds holding

Funds holding: 191185 (-6)

18% less capital invested

Capital invested by funds: $568M → $468M (-$99.5M)

Holders
185
Holders Change
-6
Holders Change %
-3.14%
% of All Funds
4.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
32
Increased
72
Reduced
46
Closed
34
Calls
$1.01M
Puts
$566K
Net Calls
+$446K
Net Calls Change
-$1.48M
Name Holding Trade Value Shares
Change
Change in
Stake
BC
51
Birchview Capital
Vermont
$648K +$43.7K +10,000 +6%
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
$616K +$527K +120,616 +201%
FIM
53
Fernwood Investment Management
Massachusetts
$612K -$20.4K -4,660 -3%
Marshall Wace
54
Marshall Wace
United Kingdom
$597K +$267K +60,987 +54%
TCM
55
Tekla Capital Management
Massachusetts
$574K
William Blair & Company
56
William Blair & Company
Illinois
$566K -$51.6K -11,798 -7%
Axa
57
Axa
France
$541K +$381K +87,100 +122%
PPA
58
Parametric Portfolio Associates
Washington
$529K +$147K +33,726 +28%
Russell Investments Group
59
Russell Investments Group
United Kingdom
$519K +$349K +79,837 +111%
UBS AM
60
UBS AM
Illinois
$512K -$164K -37,561 -20%
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$480K +$1.45K +332 +0.2%
Barclays
62
Barclays
United Kingdom
$464K -$663K -151,729 -53%
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
$444K
Voloridge Investment Management
64
Voloridge Investment Management
Florida
$425K +$228K +52,250 +72%
UBS Group
65
UBS Group
Switzerland
$422K -$383K -87,687 -41%
SG Americas Securities
66
SG Americas Securities
New York
$421K +$450K +103,014 +501%
GCP
67
GSA Capital Partners
United Kingdom
$382K +$400K +91,557 +448%
CS
68
Credit Suisse
Switzerland
$357K -$39.3K -8,980 -8%
Manulife (Manufacturers Life Insurance)
69
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$356K +$68.2K +15,599 +18%
TFCP
70
Twin Focus Capital Partners
Massachusetts
$355K +$844 +193 +0.2%
GAM
71
Gotham Asset Management
New York
$352K +$95.7K +21,882 +27%
VEA
72
Virtus ETF Advisers
New York
$342K -$64K -14,644 -13%
AIG
73
American International Group
New York
$341K +$40.3K +9,210 +10%
Osaic Holdings
74
Osaic Holdings
Arizona
$325K +$416K +95,130 New
Stifel Financial
75
Stifel Financial
Missouri
$320K -$8.66K -1,980 -2%

IMGN Hedge Fund Activity: Q1 2020 in Review

185 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2020, worth a combined $468M — down 18% from $568M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of IMGN and 32 opened new positions — a net loss of 2 holders — while 46 trimmed existing stakes and 72 added.

The largest buyer was Wellington Management Group, adding an estimated $83.5M. The largest seller was Morgan Stanley, cutting an estimated $16.2M.

  • 185 institutional investors held Immunogen Inc (IMGN) as of Q1 2020, down from 191 in Q4 2019.
  • Funds reported $468M of Immunogen Inc stock for Q1 2020, down 18% quarter-over-quarter.
  • 32 funds opened new Immunogen Inc positions in Q1 2020 and 34 closed out, a net change of -2 holders.
  • The largest Immunogen Inc buyer in Q1 2020 was Wellington Management Group, an estimated $83.5M added.
  • The largest Immunogen Inc seller in Q1 2020 was Morgan Stanley, an estimated $16.2M sold.

Based on aggregated 13F filings for Q1 2020.